Shandong Boan Biotechnology Co., Ltd.

DB:UJ9 Stock Report

Market Cap: €506.2m

Shandong Boan Biotechnology Balance Sheet Health

Financial Health criteria checks 3/6

Shandong Boan Biotechnology has a total shareholder equity of CN¥1.4B and total debt of CN¥654.2M, which brings its debt-to-equity ratio to 47%. Its total assets and total liabilities are CN¥2.5B and CN¥1.2B respectively. Shandong Boan Biotechnology's EBIT is CN¥19.8M making its interest coverage ratio 1. It has cash and short-term investments of CN¥172.1M.

Key information

47.0%

Debt to equity ratio

CN¥654.23m

Debt

Interest coverage ratio1x
CashCN¥172.12m
EquityCN¥1.39b
Total liabilitiesCN¥1.16b
Total assetsCN¥2.55b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: UJ9's short term assets (CN¥749.0M) exceed its short term liabilities (CN¥555.6M).

Long Term Liabilities: UJ9's short term assets (CN¥749.0M) exceed its long term liabilities (CN¥601.0M).


Debt to Equity History and Analysis

Debt Level: UJ9's net debt to equity ratio (34.6%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if UJ9's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: UJ9's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: UJ9's interest payments on its debt are not well covered by EBIT (1x coverage).


Balance Sheet


Discover healthy companies